Study of Rapastinel as Monotherapy in Patients With MDD

Clinical trial NCT03560518 · TERMINATED

Trial details

NCT number: NCT03560518
Sponsor: Naurex, Inc, an affiliate of Allergan plc
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Depressive Disorder, Major

Start date: 2018-06-15
Primary completion: 2019-07-08
Enrollment: 439

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.